Anthony Petrone
Stock Analyst at Mizuho
(3.77)
# 736
Out of 4,981 analysts
192
Total ratings
50%
Success rate
8.2%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALC Alcon | Maintains: Outperform | $120 → $110 | $78.29 | +40.50% | 10 | Aug 21, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $90 → $70 | $52.20 | +34.10% | 15 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $120 → $70 | $52.94 | +32.23% | 6 | Aug 7, 2025 | |
| RMD ResMed | Maintains: Outperform | $270 → $290 | $270.14 | +7.35% | 17 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Neutral | $130 → $135 | $130.31 | +3.60% | 9 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $87 → $95 | $77.57 | +22.47% | 9 | Jul 25, 2025 | |
| ABT Abbott Laboratories | Maintains: Neutral | $140 → $135 | $133.73 | +0.95% | 6 | Jul 18, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $105 → $90 | $66.68 | +34.97% | 15 | Jul 16, 2025 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $17 → $18 | $27.79 | -35.23% | 8 | Jul 16, 2025 | |
| MDT Medtronic | Maintains: Outperform | $98 → $100 | $94.03 | +6.35% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $70 | $64.45 | +8.61% | 9 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $58 → $70 | $37.35 | +87.42% | 7 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $12 | $15.14 | -20.74% | 3 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $100 | $76.22 | +31.20% | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $54.90 | +18.41% | 2 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $82.76 | +111.45% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2 | $0.46 | +334.78% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $20 | $12.27 | +63.00% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $60 | $53.94 | +11.23% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $49.36 | +17.50% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $60 | $56.20 | +6.76% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $110 | $102.71 | +7.10% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $16.11 | -13.10% | 6 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $76.44 | +37.36% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $80.05 | +212.30% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.94 | +101.73% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $449.68 | -13.27% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $92.47 | -27.54% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $103.08 | +69.77% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $11.41 | +119.11% | 3 | May 13, 2020 |
Alcon
Aug 21, 2025
Maintains: Outperform
Price Target: $120 → $110
Current: $78.29
Upside: +40.50%
Haemonetics
Aug 8, 2025
Maintains: Outperform
Price Target: $90 → $70
Current: $52.20
Upside: +34.10%
Lantheus Holdings
Aug 7, 2025
Maintains: Outperform
Price Target: $120 → $70
Current: $52.94
Upside: +32.23%
ResMed
Aug 1, 2025
Maintains: Outperform
Price Target: $270 → $290
Current: $270.14
Upside: +7.35%
Teleflex
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $130.31
Upside: +3.60%
Edwards Lifesciences
Jul 25, 2025
Maintains: Outperform
Price Target: $87 → $95
Current: $77.57
Upside: +22.47%
Abbott Laboratories
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $133.73
Upside: +0.95%
The Cooper Companies
Jul 16, 2025
Maintains: Outperform
Price Target: $105 → $90
Current: $66.68
Upside: +34.97%
STAAR Surgical Company
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $27.79
Upside: -35.23%
Medtronic
Jul 16, 2025
Maintains: Outperform
Price Target: $98 → $100
Current: $94.03
Upside: +6.35%
Jul 16, 2025
Maintains: Outperform
Price Target: $65 → $70
Current: $64.45
Upside: +8.61%
Jul 16, 2025
Maintains: Outperform
Price Target: $58 → $70
Current: $37.35
Upside: +87.42%
Jul 16, 2025
Maintains: Neutral
Price Target: $13 → $12
Current: $15.14
Upside: -20.74%
Jul 16, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $76.22
Upside: +31.20%
Jun 13, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $54.90
Upside: +18.41%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $82.76
Upside: +111.45%
Apr 10, 2025
Initiates: Outperform
Price Target: $2
Current: $0.46
Upside: +334.78%
Apr 10, 2025
Initiates: Neutral
Price Target: $20
Current: $12.27
Upside: +63.00%
Apr 10, 2025
Initiates: Outperform
Price Target: $60
Current: $53.94
Upside: +11.23%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $49.36
Upside: +17.50%
Feb 26, 2025
Maintains: Outperform
Price Target: $70 → $60
Current: $56.20
Upside: +6.76%
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $102.71
Upside: +7.10%
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $16.11
Upside: -13.10%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $76.44
Upside: +37.36%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $80.05
Upside: +212.30%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.94
Upside: +101.73%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $449.68
Upside: -13.27%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $92.47
Upside: -27.54%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $103.08
Upside: +69.77%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $11.41
Upside: +119.11%